The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Losartan Teva 50 mg Film-coated Tablets

50 milligram(s) Film-coated tablet

Teva Pharma B.V.PA0749/090/003

Main Information

Trade NameLosartan Teva 50 mg Film-coated Tablets
Active SubstancesLosartan potassium
Strength50 milligram(s)
Dosage FormFilm-coated tablet
Licence HolderTeva Pharma B.V.
Licence NumberPA0749/090/003

Group Information

ATC CodeC09CA Angiotensin II antagonists, plain
C09CA01 losartan

Status

Authorised/WithdrawnAuthorised
Licence Issued20/06/2008
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available

Generics Information

Interchangeable List CodeIC0003-023-003
Interchangeable List DocumentPDF of Interchangeable List
« Back